Table 3.
Primary Outcome Measures Descriptive Statistics
| Measure | Baseline (T1) | 1 Month (T2) | 3 Months (T3) | 6 Months (T4) | ||||
|---|---|---|---|---|---|---|---|---|
| Writing | Control | Writing | Control | Writing | Control | Writing | Control | |
| Median | Median | Median | Median | Median | Median | Median | Median | |
| IQR | IQR | IQR | IQR | IQR | IQR | IQR | IQR | |
| Upper Limb Lymphedema 27 (ULL-27) | ||||||||
| Physical | 81.3 (n=49) | 85.3 (n=47) | 84.0 (n=47) | 86.7 (n=45) | 82.7 (n=47) | 84.0 (n=45) | 81.3 (n=49) | 84.0 (n=47) |
| 68.0–90.7 | 72.0–92.0 | 69.3–92.0 | 79.3–91.3 | 70.7–90.7 | 68.7–92.0 | 66.7–90.7 | 70.7–89.3 | |
| Psychological | 80.0 (n=48) | 80.0 (n=49) | 81.4 (n=44) | 80.0 (n=49) | 77.1 (n=48) | 80.0 (n=48) | 80.0 (n=48) | 82.9 (n=49) |
| 71.4–91.4 | 71.4–88.6 | 71.4–88.6 | 71.4–91.4 | 66.4–88.6 | 66.3–88.6 | 71.4–91.4 | 67.1–95.7 | |
| Social | 86.0 (n=48) | 84.0 (n=47) | 86.0 (n=46) | 84.0 (n=45) | 84.0 (n=46) | 84.0 (n=47) | 88.0 (n=48) | 84.0 (n=47) |
| 68.0–96.0 | 72.0–96.0 | 71.0–96.0 | 72.0–96.0 | 68.0–93.0 | 76.0–92.0 | 73.0–96.0 | 68.0–96.0 | |
| Overall ULL-27 | 81.5 (n=46) | 83.7 (n=45) | 83.7 (n=41) | 83.7 (n=43) | 79.3 (n=43) | 81.5 (n=43) | 81.1 (n=46) | 84.4 (n=45) |
| 66.5–92.0 | 71.5–90.4 | 70.0–90.4 | 73.3–88.9 | 66.7–89.6 | 70.4–89.6 | 69.3–89.6 | 70.0–88.9 | |
| Functional Assessment of Cancer Therapy - Breast (FACT-B) | ||||||||
| Physical WB | 23.0 (n=50) | 24.0 (n=51) | 23.0 (n=49) | 24.0 (n=51) | 24.0 (n=50) | 24.0 (n=51) | 23.0 (n=50) | 25.0 (n=51) |
| 19.7–25.2 | 21.0–27.0 | 19.0–26.0 | 22.0–26.0 | 19.7–26.0 | 21.0–26.0 | 19.0–26.0 | 20.0–26.0 | |
| Social WB | 23.0 (n=50) | 24.0 (n=51) | 21.0 (n=49) | 23.0 (n=51) | 22.0 (n=50) | 24.0 (n=51) | 23.0 (n=50) | 23.0 (n=51) |
| 17.7–25.3 | 20.0–27.0 | 17.2–25.5 | 19.0–27.0 | 15.7–25.2 | 19.0–27.0 | 18.5–25.2 | 17.0–26.8 | |
| Emotional WB | 19.5 (n=50) | 20.0 (n=51) | 20.0 (n=49) | 20.0 (n=51) | 19.0 (n=50) | 20.0 (n=51) | 20.0 (n=50) | 20.0 (n=51) |
| 16.0–23.0 | 17.0–23.0 | 14.5–22.0 | 17.0–22.0 | 16.7–23.0 | 18.0–22.0 | 17.0–22.0 | 17.0–22.0 | |
| Functional WB | 20.0 (n=50) | 22.0 (n=51) | 21.0 (n=49) | 21.0 (n=51) | 22.0 (n=50) | 21.0 (n=51) | 21.0 (n=50) | 20.0 (n=51) |
| 16.0–25.0 | 17.0–26.0 | 14.5–25.0 | 16.0–25.0 | 17.0–24.0 | 15.0–25.0 | 18.0–24.0 | 15.0–25.0 | |
| Breast Subscale | 25.5 (n=50) | 23.0 (n=51) | 24.0 (n=49) | 24.0 (n=51) | 24.0 (n=50) | 22.0 (n=51) | 25.0 (n=50) | 23.0 (n=51) |
| 20.0–28.0 | 18.0–27.0 | 18.5–28.0 | 19.0–28.0 | 19.0–29.0 | 19.0–27.0 | 20.0–28.3 | 18.0–27.0 | |
| Total FACT-B | 108.5 (n=50) | 114.0 (n=51) | 112.0 (n=49) | 113.0 (n=51) | 114.6 (n=50) | 106.0 (n=51) | 112.7 (n=50) | 112.0 (n=51) |
| 89.5–123.7 | 94.7–125.0 | 86.0–122.2 | 95.0–123.0 | 91.0–125.0 | 95.0–124.0 | 89.0–122.1 | 89.0–122.0 | |
Note. IQR=Interquartile Range; WB=well-being; Data were missing at random.